Article info
PDFMultiple sclerosis
Research paper
Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study
- Correspondence to Dr Helen Tremlett, Medicine (Neurology), University of British Columbia, Vancouver V6T 2B5, Canada; helen.tremlett{at}ubc.ca
Citation
Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study
Publication history
- Received October 20, 2017
- Revised February 26, 2018
- Accepted March 3, 2018
- First published March 30, 2018.
Online issue publication
March 02, 2020
Article Versions
- Previous version (13 September 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.